Utilization of substituted imidazo1,2-a-pyridine compounds in pharmaceutical formulations

摘要

Methods of using pharmaceutical formulations with imidazo1,2-a-pyridine compounds as active ingredients to inhibit nitric oxide synthase are disclosed. Treatments of certain conditions using imidazo1,2-a-pyridine compounds are also disclosed.